Ypsomed reduces sales and profit forecasts and appoints new CEO

Press Releases Ypsomed Group

Burgdorf - Ypsomed today has to issue an ad-hoc information due to lower than expected orders for insulin pen systems. Therefore sales and profitability for the business year 2006/07 will be lower than forecasted so far. At the same time Ypsomed announced the change of the CEO.

En savoir plus...

Ypsomed's OptiClik pen production back on track

Press Releases Ypsomed Group

Burgdorf - Ypsomed has resumed production of the dialling unit for the OptiClik pen system as planned following an intensive optimisation phase.

En savoir plus...

Ypsomed acquires additional production facilities in Solothurn

Press Releases Ypsomed Group

Burgdorf - Ypsomed has substantially increased its production capacity over the last 24 months and is acquiring additional Ziegelmattareal property at Ypsomed's Solothurn site from Ascom for CHF 12.45 million with effect from 1st July 2006.

En savoir plus...

Ypsomed 2005/06 business year

Press Releases Ypsomed Group

Burgdorf - In its business year 2005/06 Ypsomed has once again succeeded in significantly surpassing its previous year’s results. Consolidated sales of the Ypsomed Group rose by 28.4% from CHF 241.8 million to CHF 310.6 million.

En savoir plus...

Ypsomed increases free float to 30%

Press Releases Ypsomed Group

Burgdorf - With the placement of 3.2% shares previously held by majority shareholder Willy Michel and BV Holding AG, the free float of Ypsomed Holding AG was increased to 30%. Neither Willy Michel nor BV Holding AG will sell any additional shares for the time being.

En savoir plus...